Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease

Annals of Hepatology

Volumn 10, Issue 1, 2011, Pages 50-55

  Aller, Rocio ^a,b   Castrillon, Jose Luis Perez ^a   de Luis, Daniel Antonio ^a   Conde, Rocio ^a   Izaola, Olatz ^a   Sagrado, Manuel González ^a   Velasco, María Concepción ^a   Alvarez, Tomas ^a,b   Pacheco, David ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Adipose tissue; Non alcoholic fatty liver disease; Obesity; Osteocalcin

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

EID: 79956034859     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31587-x     Document Type: Article

References (22)

1. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chemistry 2004; 50: 1511-1525.
2. Lee NK, Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends in Endocrinology and Metabolism 2009; 19: 161-166.
3. Hauschka PV. Osteocalcin and matrix Gla protein:vitamin K dependent proteins in bone. Physiol Rev 1989; 69: 990-1047.
4. Price PA. Gla-containing proteins of bone. Connect Tissue Res 1989; 21: 51-57.
5. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, COnfavreux C, DAcquin R, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-469.
6. George J, Ganesh HK, Acharya S, Bandgar T, Shivane V, Karvat A, et al. Bone mineral density and disorders of mineral metabolis in chronic liver disease. W J Gastroenterology 2009; 15: 3516-3522.
7. Pietschmann P, Resch H, Muller Ch, Woloszczuk W, Willnonseder R. Decreased serum ostoecalcin levels in patients with liver cirrhosis. Bone and mineral 1990; 8: 103-108.
8. Ludwig J, Viggiano TR, McGill DB, Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiencies with a hitherto unnamed disease. Mayo Clinic Proc 1980; 55: 434-438.
9. Standards of medical carein Diabetes 2007. Diabetes Care 2008; 30: s4-s41.
10. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF. Homesotasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-414.
11. Pichard C, Slosman D, Hirschel B, Kyle U. Bioimpedance analysis in patients: an improved method for nutritional follow up. Clin Res 1993; 41: 53.
12. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16.
13. Bondini S, Kleiner DE, Goodman ZD, Gramlich T, Younossi ZM. Pathologic assesment of non-alcoholic fatty liver disease. Clin Liver Dis 2007; 11: 17-23.
14. Venturi C, Zoppini G, Zamboni C, Muggeo M: Insulin sensivity and hepatic steatosis in obese subjects with normal glucose tolerance. Nutr Metab Cardiovsc Dis 2004: 14: 200-204.
15. Browning JD, Horton JD: Molecular mediators of hepatic steatosis and liver injury. The J of Clin Invest 2004: 114: 147-152.
16. Kindblom JM, Ohlsson C, Ljunggren O, Karlsson M, Tivesten A, Smith U, Mellstrom D. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J of Bone and Mineral Research 2009; 24: 785-791.
17. Gerdhem P, Isaksson A, Akesson K, Obrant KJ. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporosis Int 2005; 16: 1506-1512.
18. Khosla S, Atkinson EJ, Riggs BL, Melton LJ. Relationship between body composition and bone mass in women. J Bone Miner Res 1996; 11: 857-863.
19. Pittas A, Harris S, ELiades M, Stark P, Dawson B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrin Metab 2008 as doi:10.1210/jc.2008-1422.
20. Szalay F, Lakatos P, Németh J, Abonyi M, Büki B, Tarján G, Holló I. Decreased serum osteocalcin level in non-alcoholic and alcoholic chronic liver diseases. Orv Hetil 1991; 132(24): 1301-1305.
21. Feron M, Hinoi E, KArsenty G, Ducy P. Osteocalcin differentally regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild type mice. Proc Natl Acad Sci USA 2008; 105: 5266-5270.
22. Saleem U, Mosley TH Jr, Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010; 30(7): 1474-1478.